Study Details

Treatment of Resistant Depression in Adolescents 2 — TORDIA 2

Gregory N. Clarke, Principal Investigator
Frances L. Lynch, Co-Investigator

This study compared four strategies for treating SSRI-resistant adolescent depression. The study involved 400 adolescents (aged 12-18) who continue to be depressed despite adequate treatment with an SSRI antidepressant used in community practice (i.e., fluoxetine, citalopram, escitalopram, sertraline).
Funding source: National Institute of Mental Health

Our Locations
Three Regions — One Mission
Each CHR site conducts professionally independent, public domain research and disseminates its findings in the scholarly literature and scientific community.

Northwest
 3800 N. Interstate
Portland, OR 97227      
503.335.2400

Hawaii
 711 Kapiolani Blvd.
Suite 200
Honolulu, HI 96813
101.222.2400 		Southeast
 3495 Piedmont Road, NE
Ten Piedmont Center,
Suite 205
Atlanta, GA 30305
202.555.1212

US Map

 
Kaiser Permanente